Post-Authorization Safety Study (PASS) of Post-Marketing Surveillance for Intussusception Following Rotarix Introduction Into the Instituto Mexicano Del Seguro Social (IMSS) in Mexico.
Phase of Trial: Phase IV
Latest Information Update: 16 Mar 2013
At a glance
- Drugs RIX 4414 (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 22 Oct 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 22 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jan 2010 Planned number of patients changed from 860 to 464 as reported by ClinicalTrials.gov.